Divis Laboratories Q2 net up 29% at Rs 296 crore

Divis Laboratories today reported a 28.77% rise in standalone net profit at Rs 295.73 crore for the second quarter ended September 30.

The company had posted a net profit of Rs 229.64 crore for the corresponding period of previous fiscal, Divis Laboratories said in a filing to BSE.

Standalone total income from operations of the company also rose to Rs 964.32 crore for the quarter under review as against Rs 833.14 crore for the same period last fiscal.

Hyderabad-based drug firm is primarily engaged in manufacture of Active Pharmaceutical Ingredients (APIs) and intermediates.